Both in Pharmaceuticals
Travere Therapeutics vs PTC Therapeutics
Over the past year TVTX returned +51.7% and PTCT returned +2.1%; their daily moves had a correlation of 0.36.
TVTX +51.7% PTCT +2.1%Growth of $1, one year, split-adjusted
| Metric | TVTX | PTCT |
|---|---|---|
| Price | $52.40 | $69.38 |
| Market cap | $4.94B | $5.80B |
| Today | +6.04% | +1.85% |
| 1 month | −6.4% | +8.9% |
| 6 months | +17.1% | +4.2% |
| Year to date | +37.1% | −8.7% |
| 1 year | +51.7% | +2.1% |
| Revenue growth (YoY) | +36.2% | +69.6% |
| Gross margin | 98.7% | 93.4% |
| Net margin | −23.3% | −14.4% |
| P/E (TTM) | — | — |
| Price / sales | 7.6× | 5.0× |
| Net cash | -$131.7M | $1.59B |
| Dividend yield | — | — |
| Volatility (60d) | 37.7% | 43.6% |
| Short % of float | 12.1% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).